These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 533887)

  • 1. Hypolipidemic activity of phthalimide derivatives. 1. N-Substituted phthalimide derivatives.
    Chapman JM; Cocolas GH; Hall IH
    J Med Chem; 1979 Nov; 22(11):1399-402. PubMed ID: 533887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidemic activity of phthalimide derivatives. 3. A comparison of phthalimide and 1,2-benzisothiazolin-3-one 1,1-dioxide derivatives to phthalimidine and 1,2-benzisothiazoline 1,1-dioxide congeners.
    Chapman JM; Cocolas GH; Hall IH
    J Med Chem; 1983 Feb; 26(2):243-6. PubMed ID: 6827542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipidemic activity of phthalimide derivatives IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides.
    Chapman JM; Cocolas GH; Hall IH
    J Pharm Sci; 1983 Nov; 72(11):1344-7. PubMed ID: 6644601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.
    Chapman JM; Wyrick SD; Josée Voorstad P; Maguire JH; Cocolas GH; Hall IH
    J Pharm Sci; 1984 Oct; 73(10):1482-4. PubMed ID: 6502502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.
    Chapman JM; Voorstad PJ; Cocolas GH; Hall IH
    J Med Chem; 1983 Feb; 26(2):237-43. PubMed ID: 6131131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V.
    Sena VL; Srivastava RM; Silva RO; Lima VL
    Farmaco; 2003 Dec; 58(12):1283-8. PubMed ID: 14630240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of a series of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimides in rodents.
    Hall IH; Wong OT; Futch G; Scovill JP
    Biomed Biochim Acta; 1990; 49(1):103-13. PubMed ID: 2360899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperlipidemic activity of phthalimide analogues in rodents.
    Hall IH; Voorstad PJ; Chapman JM; Cocolas GH
    J Pharm Sci; 1983 Aug; 72(8):845-51. PubMed ID: 6620134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic activity of phthalimide derivatives. 7. Structure-activity studies of indazolone analogues.
    Wyrick SD; Voorstad PJ; Cocolas G; Hall IH
    J Med Chem; 1984 Jun; 27(6):768-72. PubMed ID: 6737419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents.
    Chapman JM; DeLucy P; Wong OT; Hall IH
    Lipids; 1990 Jul; 25(7):391-7. PubMed ID: 2395418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and hypolipidemic activity of N-phthalimidomethyl tetra-O-acyl-alpha-D-mannopyranosides.
    Srivastava RM; Oliveira FJ; da Silva LP; de Freitas Filho JR; Oliveira SP; Lima VL
    Carbohydr Res; 2001 Jun; 332(3):335-40. PubMed ID: 11376613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential hypolipidemic agents derived from 3-hydroxy-17,17-dimethylgona-1,3,5(10),8,11,13-hexaene.
    Chinn LJ; Salamon KW
    J Med Chem; 1977 Feb; 20(2):229-33. PubMed ID: 836494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.
    Hall IH; Murthy AR; Wyrick SD
    J Pharm Sci; 1986 Jun; 75(6):622-6. PubMed ID: 3735111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic arylthioalkanoic acids.
    Wagner ER; Dull RG; Mueller LG; Allen BJ; Renzi AA; Rytter DJ; Barnhart JW; Byers C
    J Med Chem; 1977 Aug; 20(8):1007-13. PubMed ID: 894671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the hypolipidemic activity of cyclic vs. acyclic imides.
    Voorstad PJ; Chapman JM; Cocolas GH; Wyrick SD; Hall IH
    J Med Chem; 1985 Jan; 28(1):9-12. PubMed ID: 3965717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic imidazoles.
    Baggaley KH; Heald M; Hindley RM; Morgan B; Tee JL; Green J
    J Med Chem; 1975 Aug; 18(8):833-6. PubMed ID: 1159701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic activity of indan-1,3-dione derivatives in rodents.
    Murthy AR; Wyrick SD; Hall IH
    J Med Chem; 1985 Nov; 28(11):1591-6. PubMed ID: 4067989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance.
    da Silva Júnior JG; de Araújo HDA; da Rocha IG; da Silva Neto JC; Oliveira RN; de Oliveira Assis SP; de Menezes Lima VL
    Chem Biodivers; 2022 Oct; 19(10):e202200119. PubMed ID: 36094678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives.
    Dygos JH; Jett CM; Chinn LJ; Miller JE
    J Med Chem; 1977 Dec; 20(12):1705-8. PubMed ID: 592342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic substituted 1,3-benzodioxole-2-carboxylates.
    Grisar JM; Claxton GP; Parker RA; Palopoli FP; Kariya T
    J Med Chem; 1974 Jul; 17(7):721-5. PubMed ID: 4836402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.